Maltodextrin

Phase 2Small molecule

RRDC Clinical Pty Ltd

Maltodextrin is one of 110 small molecule programs targeting Insulin resistance. It is currently in Phase 2.

Indications

Total Trials

Active Trials

109

Competitors

Pipeline

Status by Indication[3][1]

Indication

Insulin ResistanceActive, not recruiting

RetinopathyActive, not recruiting

Multiple SclerosisActive, not recruiting

Knee OsteoarthritisNot yet recruiting

PouchitisActive, not recruiting

Insulin ResistancePhase 2

Active, not recruiting

RetinopathyPhase 2/Phase 3

Active, not recruiting

Multiple SclerosisPhase 2

Active, not recruiting

Knee OsteoarthritisPhase 2

Not yet recruiting

PouchitisPhase 1

Active, not recruiting

Competition

Competitive Landscape

560 competitors in Multiple Sclerosis

#DrugCompanyPhaseTrials

Maltodextrin

RRDC Clinical Pty Ltd

Phase 2

1 2

Betaseron

Bayer

Preclinical

16 3

Kesimpta

Novartis

Preclinical

15 4

Tysabri

Biogen

Preclinical

14 5

Avonex

EMD Serono

Preclinical

22 6

Campath

GGenzyme, a Sanofi Company

Preclinical

12 7

Zinbryta

Roche

Preclinical

2 8

Flomax

Sanofi

Preclinical

1 9

Pred Forte

Myfortic

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Post-ApprovalNot yet recruiting

Cardiac Surgery

NCT05188222

Q3 2027

Phase 2Not yet recruiting

Knee Osteoarthritis

NCT07189585

Clinical

Trials by Indication[1]

Inflammation2 trials

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation, and Muscle Comfort in an Otherwise Healthy Population

Completed·RRDC Clinical Pty Ltd·Phase 3·NCT06436781·33 enrolled

Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

Completed·RRDC Clinical Pty Ltd·Phase 3·NCT06444763·97 enrolled

Insulin resistance2 trials

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)

Completed·TThe University of Texas Health Science Center at San Antonio·Phase 2·NCT02127125·69 enrolled

Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)

Completed·TThe University of Texas Health Science Center at San Antonio·Phase 2·NCT02124759·20 enrolled

Gastrointestinal1 trial

Effect of Maolactin on Gastrointestinal Tract (GIT) Health

Completed·RRDC Clinical Pty Ltd·Phase 3·NCT06104917·91 enrolled

Effectiveness1 trial

Effectiveness of a Grape Seed Extract on Circulatory Measures in Healthy Adults

Completed·RRDC Clinical Pty Ltd·Phase 3·NCT06440252·35 enrolled

Constipation1 trial

GOS Prebiotic Effect in Children Constipation

Completed·UUniversity of Campinas, Brazil·Phase 1·NCT02183766·20 enrolled

8 more indications

Pouchitis1 trial

Study of Sc-FOS for Pouchitis Prevention

Completed·MMayo Clinic·Phase 1·NCT02203955·13 enrolled

Alcohol Use Disorder1 trial

Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder

Completed·AAnders Fink-Jensen, MD, DMSci·Phase 2·NCT05416229·60 enrolled

Retinopathy1 trial

A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy

Unknown status·PPrim. Prof. Dr. Oliver Findl, MBA·Phase 2/3·NCT02215330·60 enrolled

Multiple Sclerosis1 trial

Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis

Unknown status·MMedical University of Vienna·Phase 2·NCT01879202·96 enrolled

Resistance1 trial

Effects of High-velocity Resistance Training and Creatine Supplementation in Healthy Aging Males

Unknown status·UUniversity of Regina·Phase 2·NCT03530202·40 enrolled

Cardiac Surgery1 trial

Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Not yet recruiting·JJewish General Hospital·Phase 4·NCT05188222·70 enrolled

Knee Osteoarthritis1 trial

Change in LPS With Inulin Supplementation and Its Association With Knee Pain Among Older Adults With Osteoarthritis

Not yet recruiting·YYale University·Phase 2·NCT07189585·84 enrolled

Unspecified1 trial

Effect of a Synbiotic on Symptoms of Patients With STC

Completed·JJinling Hospital, China·Phase 2·NCT02844426·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 15 trial records for Maltodextrin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Maltodextrin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Maltodextrin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — RDC Clinical Pty Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: RRDC Clinical Pty Ltd

Maltodextrin

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Q3 2027

Trials by Indication[1]

Inflammation2 trials

Insulin resistance2 trials

Gastrointestinal1 trial

Effectiveness1 trial

Constipation1 trial

Pouchitis1 trial

Alcohol Use Disorder1 trial

Retinopathy1 trial

Multiple Sclerosis1 trial

Resistance1 trial

Cardiac Surgery1 trial

Knee Osteoarthritis1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News